Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine Augmentation in OUD with SMI
NCT05179772Phase 2Withdrawn
- Sponsor
- University of Pennsylvania
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in opioid use disorder (OUD), sponsored by University of Pennsylvania. Planned start Jul 2022; status: withdrawn.
02
Drugs
olanzapine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05179772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05179772.